Antibody levels against respiratory syncytial virus fusion protein conformations and lack of association with life-threatening infection in previously healthy infants
Author:
Bonnin Florencia A.ORCID,
Talarico Laura B.ORCID,
Ferolla Fausto M.ORCID,
Acosta Patricio L.,
Phung EmilyORCID,
Kumar Azad,
Toledano Analía,
Caratozzolo AnaORCID,
Neira Pablo,
Mascardi Normando,
Satragno Daniela,
Contrini María M.ORCID,
Graham Barney S.ORCID,
Ruckwardt Tracy J.ORCID,
López Eduardo L.
Reference45 articles.
1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study;Shi;Lancet,2017
2. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in children younger than 5 years in 2019: a systematic analysis;Li;Lancet,2022
3. Excess child mortality after discharge from hospital in Kilifi, Kenya: a retrospective cohort analysis;Moisi;Bull World Health Organ,2011
4. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis;Nair;Lancet,2010
5. Carroll KN, Hartert TV. The impact of respiratory viral infection on wheezing illnesses and asthma exacerbations. Immunol Allergy Clin North Am 2008;28:539–61, viii. doi: 10.1016/j.iac.2008.03.001.